Boston Scientific (NYSE:BSX – Get Free Report) had its price target increased by analysts at Robert W. Baird from $79.00 to $84.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical equipment provider’s stock. Robert W. Baird’s target price would indicate a potential upside of […]